Chimerix Announces Initiation of a Phase 2/3 Study of DSTAT in Acute Lung Injury for Patients with Severe COVID-19

NEXT STORY
TG Therapeutics Bolsters Board of Directors with the Appointment of Sagar Lonial, MD
PREV STORY
Teleflex to Present at the Bank of America Merrill Lynch 2020 Health Care Conference
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Kura Oncology to Participate in Two Upcoming Investor Conferences

SAN DIEGO, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a ...

author_avatar
NASDAQ Market News

PATIENT WITH “FLESH EATING DISEASE”ON HER LEG WALKS OUT OF SUNRISE HOSPITAL AND MEDICAL CENTER

Las Vegas, NV, June 01, 2017 (GLOBE NEWSWIRE) -- Sunrise Hospital and Medical Center ...

author_avatar
NASDAQ Market News

Medigene announces outlicensing of AAVLP technology

2A Pharma AB to continue development of AAVLP based vaccines             Martinsried/Munich, 20 December 2016. Medigene ...

author_avatar
NASDAQ Market News